UTI AMC Q4 FY26 Results: FY26 Standalone PAT ₹460 Crore, Revenue ₹1,255 Crore, Dividend ₹40/Share

April 24, 2026
Posted by: sachet
Category: News

UTI AMC Q4 FY26 results are out, with one of India’s oldest mutual fund houses reporting full-year standalone core income from services of ₹1,255.17 crore (up from ₹1,179.68 crore in FY25) and normalised core PAT of ₹460 crore, modestly higher than ₹447 crore in FY25. UTI AMC Q4 standalone results show revenue resilience against a backdrop of competitive pressure in the Indian mutual fund industry.

On a consolidated basis, UTI AMC Q4 FY26 core income from services reached ₹1,538.92 crore versus ₹1,445.31 crore in FY25. However, UTI AMC Q4 consolidated profit attributable to owners declined to ₹404.12 crore from ₹731.49 crore in FY25 — reflecting higher operating costs and changes in the performance of subsidiary/associate entities.

UTI AMC Q4 board recommended a final dividend of ₹40 per equity share of face value ₹10 for FY26, demonstrating the company’s commitment to returning capital to shareholders. UTI AMC Q4 also completed a Voluntary Retirement Scheme (VRS) during FY26 aimed at rationalising its cost structure.

Table of Contents

UTI AMC Q4 FY26 Results Date and Dividend

Get real-time stock research and expert analysis on Univest.

UTI AMC Q4 FY26 results were declared at the board meeting held on April 23, 2026 (commenced 2:00 PM, concluded 5:30 PM IST). UTI AMC is one of India’s oldest mutual fund managers — established in 1964 as Unit Trust of India. UTI AMC manages AUM across equity, debt, hybrid, and ETF categories, serving retail and institutional investors. UTI AMC Q4 dividend record date will be announced separately.

Company	Q4 Results Date	Status
TCS	April 9, 2026	Declared
HCL Technologies	April 21, 2026	Declared
UTI AMC	April 23, 2026	Declared
Infosys	April 23, 2026	Declared

TCS Q4 FY26 results were declared April 9. Analysis at Univest Blogs — TCS Q4 FY26 Results.

Why UTI AMC Q4 FY26 Results Matter

UTI AMC Q4 results are significant because they reflect how a legacy AMC is managing the transition from an institutionally-dominated, government-focused business to a competitive retail mutual fund manager. UTI AMC Q4 has been losing AUM market share to private sector AMCs (HDFC, SBI MF, ICICI Pru) over the past decade — its FY26 results will show whether the decline has stabilised.

UTI AMC Q4 VRS completion and the restructuring narrative are the central elements of the investment thesis — can the company reduce its legacy cost structure to industry-competitive levels while growing AUM through digital distribution? UTI AMC Q4 consolidated profit decline versus standalone improvement also raises questions about subsidiary performance that management will need to address.

UTI AMC Q4 FY26 – Financial Results

UTI AMC Q4 FY26 standalone normalised core PAT of ₹460 crore (+3% YoY) shows modest improvement. UTI AMC Q4 Q4 standalone core income from services was ₹305.11 crore versus ₹295.73 crore in Q4 FY25 — a healthy sequential and YoY improvement. UTI AMC Q4 the consolidated PAT decline (₹404 crore vs ₹731 crore in FY25) likely reflects changes in the performance fee income of subsidiary entities and VRS restructuring costs.

Access premium research on Univest.

Metric	FY25	FY26	YoY Change	Notes
Standalone Core PAT (₹ Cr)	447	460	+3%	Modest improvement
Standalone Revenue (₹ Cr)	1,180	1,255	+6.4%	Healthy growth
Consolidated PAT (₹ Cr)	731.49	404.12	↓45%	Subsidiary impact
Final Dividend (₹/share)	—	40	—	Face value ₹10

UTI AMC Q4 the gap between standalone (modestly positive) and consolidated (significant decline) profitability requires explanation at the management call. UTI AMC Q4 AUM market share — the most important long-term metric — and the net fresh inflows trend across equity and debt categories will be the key investor focus.

Screen UTIAMC fundamentals on the Univest Screener.

5 Key Factors That Will Drive UTI AMC Q4 FY26 Performance

India MF Industry AUM Crossing ₹65 Lakh Crore

UTI AMC Q4 benefits from the secular growth of India’s mutual fund industry — total AUM crossed ₹65 lakh crore in FY26 as SIP inflows hit record monthly levels above ₹25,000 crore. UTI AMC Q4 management fee income grows proportionally with industry AUM, providing a rising tide tailwind.

VRS Completion: Cost Rationalisation Underway

UTI AMC Q4 Voluntary Retirement Scheme reduces UTI AMC’s legacy employee count — a legacy of its government-owned past when headcount was not optimised for commercial efficiency. UTI AMC Q4 post-VRS cost structure should be more competitive with private AMCs by FY27, improving operating leverage.

ETF and Passive Fund Business Growing

UTI AMC Q4 ETF portfolio — including Nifty 50 ETF and sector ETFs — has been gaining AUM from institutional investors and retail investors accessing markets through low-cost index funds. UTI AMC Q4 passive AUM growth is faster than active equity, aligning with the global ETF adoption trend.

Strong Debt Fund Franchise

UTI AMC Q4 debt fund franchise — government bond, gilt, and liquid funds — remains one of India’s strongest. UTI AMC Q4 debt AUM from institutional treasuries, provident funds, and insurance companies provides stable management fee income. UTI AMC Q4 government securities expertise, built over decades as the government’s primary investment manager, is a structural competitive advantage.

₹40 Dividend — Capital Return to Shareholders

UTI AMC Q4 final dividend of ₹40/share (total yield of approximately 3% at current market price) demonstrates the company’s commitment to shareholder returns. UTI AMC Q4 regular dividend payment to public shareholders — on a face value of ₹10 — positions the stock as an income investment alongside the growth opportunity from MF industry expansion.

5 Risks to Watch in UTI AMC Q4 FY26

AUM Market Share Erosion to Private AMCs

UTI AMC Q4 AUM market share has been steadily declining from a historical dominance to its current position of approximately 6–7% of industry AUM. UTI AMC Q4 faces structural competition from HDFC AMC and SBI MF, which have stronger equity fund performance track records and superior digital distribution ecosystems.

Consolidated PAT Decline – Subsidiary Performance Concerns

UTI AMC Q4 consolidated PAT of ₹404 crore (↓45% from ₹731 crore in FY25) raises questions about subsidiary performance. UTI AMC Q4 subsidiary entities — including international fund management and retirement fund operations — may have faced performance fee and AUM-related pressures. The divergence between standalone and consolidated needs detailed explanation.

Equity Fund Performance Risk

UTI AMC Q4 active equity fund performance — versus benchmarks — is the critical driver of retail investor flows. If UTI AMC Q4 flagship equity funds underperform their benchmarks for two or more consecutive years, fund rating agencies downgrade the schemes, triggering net outflows. Active equity fund performance management remains the company’s most critical execution variable.

Competition from New-Age Digital AMCs

UTI AMC Q4 faces competition from digitally-native AMCs and distribution platforms (Groww, Zerodha Coin, Paytm Money) that are attracting younger investors with low-cost index funds and superior digital UX. UTI AMC Q4 legacy customer acquisition model is less effective with digital-first millennials and Gen Z investors.

Regulatory Fee Compression

SEBI has historically imposed TER cuts that reduce per-rupee-AUM fee income for AMCs. UTI AMC Q4 faces the risk of further regulatory interventions on management fees, particularly in equity categories where margins are highest. Any additional TER compression would directly impact UTI AMC Q4 revenue per rupee of AUM.

Conclusion

UTI AMC Q4 FY26 results show a company navigating a transformation from legacy government AMC to commercial MF manager. Standalone PAT grew modestly to ₹460 crore (+3% YoY), revenue improved 6.4%, and the ₹40 dividend signals financial discipline. The consolidated PAT decline and AUM market share narrative will be the key focus for investors. UTI AMC Q4 VRS completion and India’s MF industry tailwind provide the foundation — execution on AUM growth and active fund performance is the requirement for re-rating.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data is sourced from publicly available NSE/BSE filings and exchange announcements. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.

For more Q4 FY26 results analysis, visit Univest Blogs.

Frequently Asked Questions

What was UTI AMC Q4 FY26 PAT?

UTI AMC FY26 standalone normalised core PAT was ₹460 crore, up from ₹447 crore in FY25. Consolidated profit attributable to owners was ₹404.12 crore, down from ₹731.49 crore in FY25.

What dividend did UTI AMC declare for FY26?

UTI AMC Q4 FY26 board recommended a final dividend of ₹40 per equity share of face value ₹10 for FY26, subject to shareholder approval at the upcoming AGM.

What is UTI AMC’s AUM?

UTI AMC manages assets across equity, debt, hybrid, and ETF categories. The company is one of India’s largest AMCs with AUM primarily in debt and passive (ETF) categories.

Why did UTI AMC’s consolidated PAT decline in FY26?

UTI AMC Q4 consolidated PAT of ₹404 crore was significantly lower than FY25’s ₹731 crore, reflecting changes in subsidiary performance, higher operating costs from restructuring, and potentially lower performance fee income. Management commentary at the earnings call will provide clarity.

What is UTI AMC’s VRS?

UTI AMC completed a Voluntary Retirement Scheme (VRS) during FY26 to rationalise its legacy employee count from its government-owned past. The VRS reduces the company’s fixed employee costs and improves operating leverage for FY27 and beyond.

What were UTI AMC Q3 FY26 results?

In Q3 FY26, UTI AMC reported standalone core income from services of ₹295.73 crore and net profit fell 13% to ₹123.68 crore, reflecting ongoing cost pressures. UTI AMC Q4 showed revenue improvement.

When did TCS declare Q4 FY26 results?

TCS Q4 FY26 results were declared on April 9, 2026. Full analysis is available on Univest Blogs. Read the TCS Q4 analysis at Univest Blogs.